Recent Advances in Pharmaceutical and Biomedical Analysis
A special issue of Future Pharmacology (ISSN 2673-9879).
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 3558
Special Issue Editor
Interests: liquid chromatography; mass spectrometry; biomedical and pharmaceutical analysis; sample preparation methods; drug development; clinical trials
Special Issue Information
Dear Colleagues,
Analytical techniques and methods are constantly being developed to improve the efficiency and quality of pharmaceutical and biomedical analysis. Development and validation of reliable analytical methods are important in the analysis of drugs, metabolites, biomolecules in biological samples, and drugs or related substances in pharmaceutical formulations. Progress in pharmaceutical and biomedical sciences is often dependent on the development of analytical methods. An important role is played here by the application of innovative approaches in analytical techniques such as liquid chromatography (LC), gas chromatography (GC), capillary electrophoresis (CE), and mass spectrometry (MS). This Special Issue will cover the interdisciplinary aspects of analysis in the pharmaceutical and biomedical sciences. We sincerely invite researchers to contribute high-quality original research or review articles. Potential topics include, but are not limited to:
- development of modern analytical methods
- drug purity and stability studies
- pharmacokinetics
- therapeutic drug monitoring
- characterization and detection of new therapeutics
- metabolic studies
- drug-related aspects of forensic toxicology
- detection of illicit/recreational drugs use
Dr. Karol Wróblewski
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Future Pharmacology is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmaceutical analysis
- biomedical analysis
- separation methods
- mass spectrometry
- sample preparation
- analytical method development
- validation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
